One-year outcomes of a NeoHexa sirolimus-eluting coronary stent system with a biodegradable polymer in all-comers coronary artery disease patients: Results from NeoRegistry in India

Table 1 Demographic and baseline clinical characteristics

Characteristics	n = 129 patients
Patient demographics
Age, yr	56.57 ± 11.73
Male	99 (76.74)
Baseline medical history
Diabetes mellitus	51 (39.53)
Hypertension	64 (49.61)
Smoking	11 (8.53)
Family history of coronary artery disease	04 (3.10)
History of alcohol consumption	05 (3.88)
Renal disease	01 (0.77)
Atrial fibrillation	01 (0.77)
Cardiac status - Angina class
I	08 (6.20)
II	26 (20.15)
III	71 (55.04)
IV	23 (17.83)
Unknown	01 (0.77)

Data presented as mean ± SD or n (%).

Table 2 Lesion and procedural characteristics (n = 129 patients and 172 lesions)

Characteristics	n = 172 lesions
Target vessel location
LAD	73 (42.44)
LCx	37 (21.51)
RCA	56 (32.56)
Ramus	03 (1.74)
Other	03 (1.74)
Target lesion location
Ostial	05 (2.91)
Proximal	83 (48.26)
Mid	54 (31.39)
Distal	22 (12.79)
Unknown	08 (4.65%)
Lesion length
< 20 mm	39 (22.67)
20–40 mm	124 (72.09)
> 40 mm	08 (4.65)
Stenosis	88.12
Bifurcation	3 (1.74)
Thrombotic lesions	16 (9.30)
ACC/AHA lesion type
A	09 (5.23)
B	92 (53.49)
C	71 (41.28)
TIMI flow grade at baseline
0	45 (26.16)
1	49 (28.49)
2	72 (41.86)
3	05 (2.91)
Unknown	01 (0.58)
Average stent length	27.30 ± 9.20
Average stent diameter	2.98 ± 0.69
Average stent per patient	1.34 ± 0.53
Predilation	168 (97.67)
Postdilation	45 (26.16)

Data presented as mean ± SD or n (%). ACC: American College of Cardiology; AHA: American Heart Association; LAD: Left anterior descending; LCx: Left circumflex; RCA: Right coronary artery; TIMI: Thrombolysis in myocardial infarction.

Table 3 Mortality, morbidity, and major adverse cardiac event, n (%)

Events	In-hospital	1 mo	6 mo	1 yr
MACE	0	01 (0.78)	05 (3.94)	06 (4.87)
Death	0	01 (0.78)	03 (2.36)	03 (2.44)
Myocardial infarction	0	0	01 (0.79)	01 (0.81)
Clinically driven TLR	0	0	01 (0.79)	02 (1.63)

MACE: Major adverse cardiac event; TLR: Target lesion revascularization.

Table 4 Stent thrombosis, n (%)

Timing of stent thrombosis	Incidence	Type of stent thrombosis	Incidence
Early	0	Definite	0
Late	01 (0.78)	Probable	02 (1.55)
	01 (0.78)	Possible